ArticleVaccine2022

Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?

Lotus L van den Hoogen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.